Sign in Subscribe

screening-procedure

A collection of 109 issues

WhatsApp chatbot outreach improves colorectal cancer screening uptake

Skip to content The CRC Digest ▪ SCREENING WhatsApp chatbot outreach improves colorectal cancer screening uptake A randomized controlled trial found that a theory-based WhatsApp chatbot delivering health education and personalized risk assessment improved CRC screening uptake rates compared to standard text reminders in asymptomatic individuals aged 50-75. (Clin Gastroenterol Hepatol)

Risk-adapted FIT screening intervals may personalize colorectal cancer screening

Skip to content The CRC Digest ▪ SCREENING Risk-adapted FIT screening intervals may personalize colorectal cancer screening A modeling study based on the BLITZ cohort suggests that screening intervals for fecal immunochemical tests could be tailored based on quantitative hemoglobin levels in initially negative tests, stratifying participants into low, medium, and

Follow-Up Colonoscopy Completion After Positive Stool DNA Test in Community Practice

Skip to content The CRC Digest ▪ SCREENING Follow-Up Colonoscopy Completion After Positive Stool DNA Test in Community Practice In a real-world study of patients with positive multi-target stool DNA tests, researchers evaluated follow-up colonoscopy completion rates and advanced neoplasia findings within 365 days. (Current Medical Research and Opinion) This content

Low Cancer Risk After Negative Colonoscopy Following Positive Stool DNA Test

Skip to content The CRC Digest Low Cancer Risk After Negative Colonoscopy Following Positive Stool DNA Test Community practice data show that patients with a positive multitarget stool DNA test but negative colonoscopy had low rates of subsequent aerodigestive cancers. (Clinical and Translational Gastroenterology) This content is informational only and

FIT Performance Evaluated for Screening Younger Adults

Skip to content The CRC Digest FIT Performance Evaluated for Screening Younger Adults A multicutoff analysis examined how fecal immunochemical testing performs for colorectal cancer screening in people under 50. (Clinical Colorectal Cancer) This content is informational only and does not constitute medical advice. Always consult your oncologist or care

Updated ACS Guideline Addresses Blood Tests for Colorectal Cancer Screening

Skip to content The CRC Digest ▪ SCREENING Updated ACS Guideline Addresses Blood Tests for Colorectal Cancer Screening A JAMA article by Rubin discusses what an updated ACS guideline says about blood-based screening tests for colorectal cancer. (JAMA) This content is informational only and does not constitute medical advice. Always consult

Significant discrepancies found in early-onset CRC among neglected populations

Skip to content The CRC Digest Significant discrepancies found in early-onset CRC among neglected populations A comprehensive review evaluating genetic and molecular research on hereditary and early-onset CRC in ethnic minority, indigenous, and understudied populations found significant discrepancies in early-onset CRC presentations compared with well-studied groups, despite largely consistent Lynch

Multitarget stool DNA test shows promise over standard FIT screening

Skip to content The CRC Digest ▪ SCREENING Multitarget stool DNA test shows promise over standard FIT screening A systematic review found that multitarget stool DNA (mt-sDNA) testing emerged as a promising alternative to faecal immunochemical test (FIT) for detecting colorectal neoplasms, particularly given FIT's low sensitivity for advanced

Anorectal Visits Offer Missed Screening Opportunity for Adults Under 50

Skip to content The CRC Digest ▪ SCREENING Anorectal Visits Offer Missed Screening Opportunity for Adults Under 50 Among 776 patients seen for benign anorectal conditions, only 60.5% of adults aged 45-49 had undergone colonoscopy in the prior 10 years, highlighting a missed opportunity to promote screening during routine visits.

Serbian cohort reveals MLH1 as predominant Lynch syndrome variant

Skip to content The CRC Digest Serbian cohort reveals MLH1 as predominant Lynch syndrome variant Germline testing of 176 high-risk individuals in Serbia identified pathogenic variants predominantly in MLH1, highlighting the need for population-specific genetic testing strategies in hereditary colorectal cancer screening. (Int J Mol Sci) This content is informational